Relay Medical Commences User Studies on Pharmatrac Medication Management Technology
Relay Medical Corp. (CSE:RELA) (OTCQB:RYMDF) (FSE:EIY2) ("Relay" or the "Company"), an engine of MedTech innovation, is pleased to announce the...
XOMA Acquires Royalty Interest Position from Agenus on Seven Assets Being Developed by Merck and Incyte
XOMA Corporation (NASDAQ: XOMA), announced today that for $15.0 million, it has acquired from Agenus (NASDAQ: AGEN) a partial interest position in the rights to...
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
NeuroMetrix (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,130,810 titled “Transcutaneous electrical...
Auris Medical Announces Results of Pre-IND Meeting With FDA For AM-201 Program
Auris Medical (NASDAQ:EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental...
Shire: Phase I conditional clearance by the European Commission
Shire (NASDAQ:SHPG) announced the publication of a scheme document relating to the recommended cash and share offer being made by Takeda Pharmaceutical...
Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
Zenith Epigenetics a wholly-owned subsidiary of Zenith Capital announced today that it has entered into a clinical trial collaboration with...
IntelGenx Announces FDA’s Acceptance of Resubmission of New Drug Application for RIZAPORT
IntelGenx (TSXV:IGX) (OTCQX:IGXT) announced that its 505(b)(2) New Drug Application resubmission for RIZAPORT oral soluble film 10 mg for the treatment...